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Expression of the nerve growth factor (NGF) receptors TrkA and
p75NTR was found to vary at the surface of PC12 cells in a cell
cycle phase-specific manner. This was evidenced by using flow
cytometric and microscopic analysis of cell populations labeled
with antibodies to the extracellular domains of both receptors.
Differential expression of these receptors also was evidenced
by biotinylation of surface proteins and Western analysis, using
antibodies specific for the extracellular domains of TrkA and
p75NTR. TrkA is expressed most strongly at the cell surface in M
and early G1 phases, whereas p75NTR is expressed mainly in
late G1, S, and G2 phases. This expression reflects the molec-
ular and cellular responses to NGF in specific phases of the cell
cycle; in the G1 phase NGF elicits both the anti-mitogenic
effect, i.e., inhibition of the G1 to S transition, and the differen-
tiation response whereas a survival effect is provoked else-
where in the cell cycle. A model is proposed relating these
responses to the surface expression of the two receptors.
These observations open the way for novel approaches to the
investigation of the mechanism of NGF signal transduction.
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Nerve growth factor (NGF) is the prototypic member of the
neurotrophin family of growth factors. Several cell types of neural
crest origin require NGF for survival both in vivo and in vitro
(Yankner and Shooter, 1982). Study of the mechanism by which
NGF exerts its action is complicated by the presence of two
receptors, the neurotrophin receptor p75NTR (Chao, 1994) and
the receptor TrkA (Kaplan et al., 1991; Barbacid, 1994). Whereas
some reports indicate that both receptors are required to transmit
the NGF signal for differentiation (Lee et al., 1992; Battleman et
al., 1993), others suggest that TrkA alone may be sufficient for
certain actions (Jing et al., 1992) and p75NTR for others, such as
the regulation of apoptosis (Rabizadeh et al., 1993; Casaccia-
Bonnefil et al., 1996; Frade et al., 1996). PC12 cells, derived from
a pheochromocytoma tumor of the rat adrenal medulla (Greene
and Tischler, 1976), have become a principal model for the study
of the NGF action. In the absence of NGF these cells proliferate
and resemble chromaffin cells in their capacity to synthesize,
store, and release catecholamines. In response to NGF, these cells
stop dividing and extend neurites, differentiating into acetylcho-
linergic cells similar to those of the sympathetic nervous system.
Rudkin and colleagues (1989) have presented evidence for the
cell cycle phase-specifc action of NGF. This neurotrophic factor
can have a dual action on PC12 cells. During the G1 phase they
respond to NGF by differentiating, whereas in the other phases
NGF permits progression through the cell cycle. The anti-
proliferative effect of NGF corresponds to an accumulation of
cells in the G1 phase of the cell cycle resulting from a block of the
G1-to-S transition (van Grunsven et al., 1996a,b). NGF signal
transduction is cell cycle phase-specific, as exemplified by a strong
induction of the proto-oncogene c-fos in G1 phase but by little or
no induction in the S or G2 phase (Rudkin et al., 1989). Because
signal transduction starts at the receptors, the expression of those
for NGF were investigated on PC12 cells in relation to the cell
cycle.
Differential expression of the NGF receptor TrkA and the
neurotrophin receptor p75NTR has been observed at the extra-
cellular surface of exponentially growing PC12 cells. TrkA is
Received Feb. 17, 1998; revised May 29, 1998; accepted June 8, 1998.
This work was supported by grants from the Association pour la Recherche contre
le Cancer (ARC; 1394), the Ligue National Contre le Cancer (LNCC; Axe Onco-
ge´ne`se et Signalization), the Rhoˆne-Alpes Region, the Centre National de la
Recherche Scientifique (Concerted French/Spanish Exchange program PICASSO),
and the Spanish Ministry for Science and Education. J.L.U. is a recipient of a Marie
Curie Postdoctoral Fellowship from the European Union and fellowships from the
LNCC, Comite´s de´partementales de la Saoˆne et Loire et de l’Ain. E.B. is a recipient
of a fellowship from the Spanish Ministry for Science and Education through the
Consejo Superior de Investigaciones Cientı´ficas. L.A.v.G. was supported by grants
from the AUTODESK DEVELOPMENT, BV, the French Ministry of Foreign
Affairs, the LNCC, and the ARC. B.B.R., D.M.Z., and G.I.E. acknowledge funding
for a concerted action network within the European Union Biomed 1 Cancer
Research program (BMH1-CT94-1471) and a shared-cost network under the
Biomed 2 Brain Research program (BMH4-CT96-0010). We thank Dr. M. Chao for
generously supplying antibodies against p75 NTR, Dr. L. F. Reichardt for generously
providing polyclonal antibodies against TrkA and p75 NTR, Dr. S. Menard for the
MGR-12 monoclonal antibodies against TrkA, Dr. T. Mitsiadis for 192-IgG anti-
bodies against p75 NTR and for stimulating discussions, and Dr. G. Guroff for his
generous gifts of NGF and PC12 cells. We also thank A. Defours for assistance in the
preparation of this manuscript.
Correspondence should be addressed to Dr. Brian Rudkin at the above address.
Dr. Urdiales’s present address: Laboratorio de Bioquı´mica y Biologı´a Molecular,
Facultad de Ciencias, Universidad de Ma´laga, Campus de Teatinos s/n, 29071
Ma´laga, Spain.
Dr. Becker’s present address: Skirball Institute for Biomolecular Medicine, New
York University Medical Center, 550 First Avenue, New York, NY 10016.
Dr. Andrieu’s present address: CHU Cochin Port-Royal, Institut National de la
Sante´ et de la Recherche Me´dicale, 27 Rue du Faubourg, 75674 Paris, France.
Dr. van Grunsven’s present address: National Institutes of Health, National
Institute of Neurological Diseases, LMB Building 36, Room 5A29, 36 Convent
Drive, Bethesda, MD 20892-4152.
Dr. Menut’s present address: Institut Jacques Monod, Unite´ Mixte de Recherche
9922, Centre National de la Recherche Scientifique, 2 Place Jussieu, 75251 Paris
Cedex 05, France.
Copyright © 1998 Society for Neuroscience 0270-6474/98/186767-09$05.00/0
The Journal of Neuroscience, September 1, 1998, 18(17):6767–6775
expressed preferentially at the surface in early G1 and M phases
of cell cycle and is not detectable in late G1, S, and G2 phases.
Biotinylation of cell surface proteins in synchronized cultures has
confirmed the differential surface expression of NGF receptors.
These observations offer new insight into the mechanism of NGF
signal transduction.
MATERIALS AND METHODS
Antibodies. Three antibodies specific for rat p75 NTR were used: two
different antibodies directed against the extracellular domain, the mono-
clonal antibody 192-IgG (1:1000 to 1:2000) (Boehringer Mannheim,
France) or the rabbit serum REX (1:2000 to 1:4000) (from Dr. L.
Reichardt, University of California, San Francisco, CA), and one rabbit
serum containing antibodies directed against the intracellular portion of
p75 NTR “9993” (from Dr. M. Chao, Skirball Institute, New York, NY).
Two different antibodies against the extracellular domain of rat TrkA
were used: the RTA antibody (from Dr. L. Reichardt) and the antibody
267 (Ab267), which was produced in rabbits against a synthetic peptide
within the extracellular domain of rat TrkA, amino acids 267–285. For
affinity purification, either the sera or the IgG preparation was applied to
a column prepared by coupling the antigenic peptide to CNBr-activated
Sepharose CL-6B. Fractions containing antibody were pooled and con-
centrated to ;0.5 mg–1 mg/ml. This antibody was used at concentrations
of 1:50 to 1:100. The antibody Sc414 was directed against amino acids
777–790 at the C terminus of rat TrkA (Santa Cruz Biotechnology, Tebu,
France) (1:40). Secondary antibodies for immunolabeling were affinity-
purified sheep IgG (Boehringer Mannheim Biochemica, Bagnolet,
France) or donkey F(Ab9)2 anti-mouse (Jackson ImmunoResearch, West
Grove, PA) and goat IgG (Sigma, St. Louis, MO) or donkey F(Ab9)2
(Jackson ImmunoResearch) anti-rabbit labeled with FITC or
R-Phycoerythrin. These were used at dilutions of 1:100 to 1:200.
Cell culture. PC12 cells were cultured routinely, as previously described
(Rudkin et al., 1989). Under these growth conditions the population
doubling time was 48–52 hr. The protocol for synchronization of the
cultures by serum starvation also was followed as described in Rudkin et
al. (1989).
Immunolabeling. Cells were harvested by mechanical agitation in PBS
and then used either as live intact cells (no fixation or permeabilization)
or fixed for 15 min at room temperature with 1% paraformaldehyde. The
cells were treated with blocking buffer [2% bovine serum albumin (BSA;
Sigma), 10% fetal calf serum (Life Technologies, Gaithersburg, MD),
PBS Ca 21- and Mg 21-free (TechGen International, Paris, France) or
DMEM (Life Technologies), and 0.02% sodium azide as preservative]
and then exposed to appropriate dilutions of antibody in blocking buffer
for 20 min on ice. After three washes in PBS, the cells were exposed to
FITC- or Phycoerythrin-labeled second antibody used at dilutions of
1:200 in blocking buffer for 20 min on ice. For intracellular labeling the
cells were grown on collagen poly-L-lysine-coated coverslips and fixed for
3 min with methanol (220°C). Microscopic observation was with an
Olympus Vanox AH2 fluorescence microscope (Tokyo, Japan).
Analysis of cell cycle distribution, subsequent to surface labeling with
antibodies, was performed by fixing the cells in cold (220°C) 70%
ethanol for 30 min on ice, followed by one wash in PBS and treatment
with RNase [Type 1 bovine pancreas (Sigma), 1 mg/ml PBS, and 0.13 mM
EGTA] for 10 min at room temperature. Before analysis, propidium
iodide (PI) was added to a final concentration of 5 mg/ml. Alternatively,
Hoechst 33342 (HO42) was added to cell suspensions at a final concen-
tration of 0.12 mg/ml. Cells were analyzed by flow cytometry as described
below.
Flow cytometric analysis. Cells were immunolabeled as described
above. Analysis was performed on a FACStar Plus flow cytometer
(Becton Dickinson, Paris, France) equipped with a 100 mW argon laser
tuned to 488 nm (Ion Laser Technology, Salt Lake City, UT). Emission
fluorescence was measured with a DF 530/30 filter for FITC and a DF
575/26 filter for Phycoerythrin. When the fluorochrome Hoechst (HO42)
was used, excitation was made with an INNOVA 300 ion laser tuned to
multiline UV with HO42 emission fluorescence measured via a DF
424/44 filter. Data acquisition and analysis were performed with Lysis II
software on a consort 340 computer (Hewlett Packard, Palo Alto, CA) or
with CellQuest software on an Apple Macintosh 650 Quadra computer.
In some experiments the cells were analyzed on a FACScan flow cytom-
eter (Becton Dickinson) equipped with an argon ion laser tuned to 488
nm. Emission fluorescence was measured with a DF 530 filter for FITC
and a DF 585 filter for PI.
Biotinylation of surface proteins. PC12 cells were synchronized by serum
starvation and restimulated by serum addition, as previously described
(Rudkin et al., 1989). At selected times the cells were harvested and
biotinylated with the ECL protein biotinylation kit (Amersham, Les Ulis,
France) according to the manufacturer’s instructions. Cells were treated
with lysis buffer [containing (in mM) 20 Tris-HCl, pH 8, 137 NaCl, 2
EDTA, 1.1 phenylmethylsulfonyl fluoride (PMSF), and 1 sodium vana-
date plus 10% glycerol, 1% Nonidet P-40, 0.15 U/ml aprotinin, and 20 mM
leupeptin], and equivalent amounts of cells were precipitated with
streptavidin-Sepharose (Pierce, Rockford, IL). Affinity precipitation and
Western blotting were performed as previously described (van Grunsven
et al., 1996a). Filters were analyzed by means of enhanced chemofluo-
rescence (ECF; Amersham) according to the manufacturer’s instruc-
tions, using a Storm PhosphorImager (Molecular Dynamics, Sunnyvale,
CA). The values obtained for TrkA or p75 NTR were normalized to the
signal obtained in serum-starved cells (considered as one).
RESULTS
Expression of NGF receptors
Exponentially growing PC12 cells were exposed to antibodies
against the NGF receptors TrkA or p75 NTR and observed by
immunofluorescence under various experimental conditions.
When paraformaldehyde-fixed, but nonpermeabilized, cells were
exposed to antibodies against the extracellular domain of TrkA
(e.g., RTA or Ab267), only a relatively small number of the cells
in an exponentially growing population was labeled (routinely
10–30%) (Fig. 1A,B). Similar quantitative results were obtained
when nonfixed cells were used, i.e., between 5 and 30% of the cell
population was labeled. When several antibodies against specific
sequences within the extracellular domain of TrkA were used
simultaneously, the fluorescence intensity of the signal increased
with no change in the percentage of cells labeled. Microscopic
observation, after fixation and permeabilization, indicated that all
of the cells expressed TrkA intracellularly in a perinuclear loca-
tion (Fig. 1E,F). This distribution resembles that of membrane
proteins, which are stored intracellularly (e.g., the glucose trans-
porter Glut4) (Rea and James, 1997). When an antibody against
the extracellular domain of p75 NTR (192-IgG) was used on non-
permeabilized cells, between 70 and 95% of the population was
labeled at the cell surface (Fig. 1C,D). Similar results were ob-
tained with REX antibody. In permeabilized cells the labeling
was also present at the cell membrane (Fig. 1G,H). This labeling
pattern is characteristic of membrane proteins that are addressed
constitutively to the plasma membrane (e.g., EGF receptor) (Ek-
strand et al., 1995).
Differential surface expression of TrkA and p75NTR
Figure 2 illustrates the results of a typical double-labeling exper-
iment of nonfixed cells, using an affinity-purified polyclonal anti-
body (Ab267) against the extracellular portion of TrkA and a
monoclonal antibody against the extracellular domain of p75NTR
(192-IgG). Approximately 90% of the cells were p75 NTR-positive
(Fig. 2b), and only 10% were positive for TrkA (Fig. 2c). When
both antibodies were used, a population having both TrkA and
p75NTR was observed (Fig. 2d). Similar observations were made
by using RTA and other antibodies directed against the extracel-
lular domain of TrkA (data not shown). These results suggest that
the cell population is heterogeneous with regard to surface ex-
pression of NGF receptors. This heterogeneity would appear to
be a reflection of the normal physiological state of the cell
population. Sorting experiments wherein enrichment in a specific
cell population was performed, followed by reculture, indicated
that the original receptor distribution can be obtained within
three to five population doublings (data not shown).
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Figure 1. Expression of NGF receptors TrkA and p75 NTR. Cell surface localization is shown in A, TrkA (Ab267), and in C, p75 NTR (192-IgG). B, D,
Light microscopic views of the fields in A and B, respectively. Intracellular localization is shown in E, TrkA (sc414), and in G, p75 NTR (REX). F, H, Light
microscopic views of the fields in E and G, respectively. Immunolabeling was performed as described in Materials and Methods. Scale bars, 10 mm.
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A function of cell cycle phase?
Our previous studies have indicated that the signal transmitted by
NGF in PC12 cells is cell cycle phase-specific, e.g., the expression
of the proto-oncogene c-fos was induced strongly in the G1 phase
of the cell cycle but very weakly or not at all in S or G2 phase
(Rudkin et al., 1989). The surface expression of NGF receptors
was investigated throughout the cell cycle to evaluate if there is a
correlation with the cell cycle phase-specific action of NGF.
Figure 3 shows the expression of TrkA and p75NTR during the
cell cycle of exponentially growing PC12 cells as evidenced with
flow cytometric analysis of asynchronous cultures. Although
p75NTR is expressed in essentially all phases of the cell cycle (Fig.
3b), TrkA is expressed mainly at the surface of cells with a 2c
DNA content (i.e., G1) (Fig. 3c).
With the use of flow cytometry, the quantitation of relative
cellular DNA content in combination with measurements of light
scattering allows for identification of cells in the G2 phase sepa-
rately from those in the M phase. In addition, this technique
allows for the characterization of cells in early G1 and late G1
phases (Geido et al., 1990). Application of this approach offers a
more detailed analysis of the NGF receptor expression through-
out the cell cycle. Results obtained from PC12 cultures are shown
to illustrate the clarity and precision of this type of analysis.
Figure 4A shows the expression of p75NTR and TrkA in early G1,
late G1, G2, and M phases of exponentially growing (i.e., asyn-
chronous) PC12 cell cultures. TrkA is expressed most highly in
the early G1 phase and at a lower level in the M phase of the cell
cycle (Fig. 4Ai–l). Identical results were obtained with rat-1
fibroblasts expressing rat TrkA (data not shown).
In contrast, p75 NTR is present to varying extents in all phases
(Fig. 4Ae–h), but its expression is higher in late G1 (Fig. 4Af) and
in G2 phases (Fig. 4Ag) and lower in early G1 (Fig. 4Ae) and in
M phases (Fig. 4Ah). Figure 4B summarizes these results in the
form of a model for p75NTR and TrkA surface expression during
the PC12 cell cycle. At the beginning of G1 the surface expression
of p75 NTR is very low, increasing to a maximum level in late G1
phase. This high expression is maintained until the beginning of
the M phase, when it drops again to a minimum level. TrkA
surface expression appears in M phase, reaching a maximum in
early G1, and then decreasing to a minimum level by late G1,
remaining so until the next M phase.
Figure 2. Flow cytometric analysis of p75 NTR and TrkA expression. Asynchronous cultures were exposed to 192-IgG (mouse monoclonal, b),
affinity-purified Ab267 (rabbit polyclonal, c), or both together (d), as described in Figure 1, without fixation. The second antibodies were Phycoerythrin-
labeled anti-mouse and FITC-labeled anti-rabbit. The control (a) is an incubation of both secondary antibodies together.
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Ratio of TrkA to p75NTR during cell cycle
Biotinylation of surface proteins was undertaken to study the
expression of NGF receptors during the PC12 cell cycle. Cells
were synchronized by serum starvation, as previously described
(Rudkin et al., 1989). At the indicated times after restimulation
with serum the cells were collected and biotinylated. Biotinylated
proteins were precipitated with streptavidin-Sepharose and ana-
lyzed by Western blot. Figure 5A shows a Western blot of biotin-
ylated proteins, using the RTA antibody. A marked increase in
the amount of TrkA can be observed at the cell surface between
37 and 52 hr after serum restimulation, when cells are in M/early
G1 phase. Figure 5B illustrates that the amount of p75NTR at the
surface of PC12 cells changes only slightly throughout the cell
cycle. No signal was detected when the blots were exposed with an
antibody against the cytoskeletal protein tubulin (data not
shown).
To quantitate the changes in the relative surface expression of
NGF receptors during the cell cycle, we normalized the signals
obtained for each receptor to the signal obtained in serum-
starved cultures. Figure 5C shows the variation in the relative
amount of TrkA to p75NTR after serum stimulation. A threefold
increase in the ratio of TrkA to p75NTR was observed between 37
and 52 hr, i.e., when cells were in M phase or early G1. In
contrast, the ratio of TrkA to p75 NTR was lower in late G1, S, and
G2 phases. These results confirm those obtained by using flow
cytometric analysis of exponentially growing populations of cells
labeled with antibodies toward the extracellular domain of each
receptor, thereby validating this approach.
DISCUSSION
The results presented herein illustrate that PC12 cells express
NGF receptors at their surface in a cell cycle-specific manner.
Interpretation of this work is dependent on a clear appreciation of
the techniques that were used in making the observations. On the
one hand, immunofluorescence resulting from the binding of
antibodies to the extracellular domain of the receptor is detected
and quantitated with flow cytometric analysis; on the other hand,
cytolocalization is confirmed by fluorescence microscopy. The
use of flow cytometry also allows for the evaluation of receptor
expression as a function of cell cycle phase in exponentially
growing populations. Such an approach does not require previous
synchronization of the cultures and therefore reflects the natural
state of the cells under optimal growth conditions. The validity of
this approach is underlined by the fact that numerous controls are
performed for each analysis. In a single double-labeling experi-
ment, for example, 12 different combinations of the various anti-
bodies are performed and analyzed. The sensitivity is evaluated
by increasing the amount of primary antibody as well as by
applying several different antibodies recognizing distinct epitopes
within the same protein. Such conditions allow for, respectively,
saturation of the available sites and amplification of the fluores-
cence signal.
A molecular approach, i.e., biotinylation of surface proteins,
followed by Western analysis, was performed to confirm or refute
the observations made with flow cytometric analysis. To obtain
populations of cells enriched in a given cell cycle phase, we first
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by using FITC-labeled anti-mouse. Cells were labeled with 192-IgG and
Ab267 as described in Figure 2 and with propidium iodide as described in
Materials and Methods. Similar results were obtained with Hoechst la-
beling for cell cycle distribution.
Figure 3. Cell cycle expression of NGF receptors. Shown are the simul-
taneous determination of cell cycle phase and the expression of p75 NTR
(192-IgG, b) and TrkA (Ab267, rabbit polyclonal, c) of exponentially
growing PC12 cells. The control (a) is an incubation with a secondary
antibody (FITC-labeled anti-rabbit) alone. Similar results were obtained
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Figure 4. Refined analysis of cell cycle expression of NGF receptors. A, Bivariate contour plots obtained in a triple-labeling experiment after gating
cells of different subpopulations and phases of the cell cycle of exponentially growing PC12. Shown are control (a–d), p75 NTR expression (e–h), and TrkA
expression (i–l ) in early G1 (a, e, i), late G1 (b, f, j), G2 (c, g, k), and M phases (d, h, l ). The control shown (a) is an incubation of a second antibody
(FITC-labeled anti-rabbit) only. Similar results were obtained by using Phycoerythrin-labeled anti-mouse. B, Model of relative expression of NGF
receptors at the surface of PC12 cells. Shown is the relative surface expression of p75 NTR (dotted line) and TrkA (solid line) during the PC12 cell cycle.
Cells were labeled with 192-IgG and Ab267 as described in Figure 2 and with Hoechst as described in Materials and Methods.
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must synchronize cultures and then allow them to proceed
through the cell cycle in a synchronous manner. The sensitivity of
this protocol, therefore, is dependent on the degree of synchrony.
Ideally, close to 100% synchrony would be required to reflect the
precise expression of a given protein as a function of cell cycle
phase. With PC12 cells the synchronization procedure that was
used offers a degree of synchrony of ;70–80% on average. This
is sufficiently high to confirm the observation made by flow
cytometric analysis, i.e., that there is an increase in the ratio of
TrkA to p75 NTR at the cell surface in M and early G1 phases.
However, the absence of TrkA in a given cell cycle phase cannot
be determined by this approach, because there is a residual signal
attributable to the unsynchronized cell population. In this regard,
flow cytometric analysis of the exponentially growing (asynchro-
nous) cultures is much more precise.
In binding studies performed on exponentially growing PC12
cultures, ;90% of the receptors on a cell are considered to be low
affinity, whereas 5–10% are high affinity (Meakin and Shooter,
1991; Weskamp and Reichardt, 1991; Mahadeo et al., 1994).
These studies reflect an average picture of the cell culture, be-
cause individual cell populations cannot be distinguished by using
such techniques. This interpretation is based, therefore, on the
assumption that all cells in the population express both types of
receptors at their surface. The present results offer a different
interpretation. Inasmuch as the TrkA/p75NTR heterodimer is
considered as the high-affinity receptor for NGF (Hempstead et
al., 1991; Battleman et al., 1993; Barker and Shooter, 1994), the
flow cytometric analysis has allowed for the detection of distinct
cell populations expressing these proteins at the cell surface.
They suggest that there are at least two subpopulations of cells—
the majority of which expresses only one type of receptor of low
affinity, whereas the remaining cells express the components
comprising the high-affinity receptor. These observations are of
particular import for the study of receptor complex formation
(i.e., homodimers or heterodimers of TrkA and p75NTR) and
NGF signal transduction in general, using the PC12 cell model.
It is well established that the presence of TrkA is essential for
the triggering of differentiation, the induction of c-fos expression,
and the anti-mitogenic effect of NGF (Loeb and Greene, 1993;
Kaplan and Stephens, 1994). If this receptor is absent in PC12
cells (or expressed at extremely low levels), these responses are
not detectable. The results presented herein clearly are in agree-
ment with these reports and offer another dimension to the
understanding of the importance of the role of each receptor in
the NGF response. In the light of our previous studies (Rudkin et
al., 1989) certain G1-specific responses to NGF (e.g., induction of
c-fos) would be a direct result of the surface expression of TrkA
in the G1 phase. The surface expression of p75NTR in late G1, S,
and G2 phases indicates that the survival /progression response
provoked by NGF in exponentially growing cells in the absence of
serum is attributable to the presence of this receptor (for discus-
sion, cf. Rudkin et al., 1989). This interpretation is supported by
reports suggesting that, depending on the cellular context,
p75NTR can stimulate a pro-apoptotic signal in the absence of
NGF that is neutralized in its presence (for discussion, cf. Bre-
desen and Rabizadeh, 1997). Another interpretation would be to
assume that TrkA is present at the cell surface during this part of
the cell cycle at levels, undetectable by the approaches described
herein, that would be too low to stimulate c-fos expression or cell
cycle arrest but that would be sufficient to permit survival. In
either case, the change in the relative amounts of TrkA to
p75NTR clearly would result in differences in signaling in re-
sponse to NGF throughout the cell cycle, differences that have
been evidenced previously (Rudkin et al., 1989).
These studies offer elucidation of the cell cycle phase-specific
action of NGF. Figure 6 illustrates a model summarizing the
results discussed in this report. In this model the physiological
response observed as a function of cell cycle phase initially is
attributable to the regulated surface expression of p75NTR and
TrkA. That TrkA is expressed at the cell surface in the M and
Figure 5. Western analysis of NGF receptors expressed at the surface of
PC12 cells. PC12 cells were synchronized by serum starvation and restim-
ulated by serum addition, as previously described (Rudkin et al., 1989). A,
TrkA surface expression. B, p75 NTR surface expression in serum-starved
cells exposed to serum. C, Changes in the ratio of TrkA to p75 NTR during
the cell cycle of PC12 cells synchronized by serum starvation. The broken
line above the graph represents the corresponding cell cycle phase, based
on cumulative analysis of the cell line over the past 8 years and on
observations of histone RNA expression, thymidine or BrdU incorpora-
tion, and cell number. RTA and 9993 were used for the detection of TrkA
and p75 NTR, respectively. Comparable results were obtained in two
separate experiments.
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early G1 phases of the cell cycle suggests that cells should commit
to differentiate at the very beginning of the cell cycle. The in vivo
studies of Waid and McLoon (1995) on the timing of differenti-
ation of ganglion cells in the developing chick retina indicate that
these cells start to differentiate very rapidly (within 15 min) after
the final mitosis. Although the actual mechanisms are not clear,
such observations speak to the importance of the cell being able
to respond to a differentiation signal at a specific moment relative
to cell division.
Regulation of surface expression of membrane proteins is a
means for modulating cellular response to surrounding stimuli.
Such considerations are evident from studies of expression of
growth factor receptors or adhesion molecules during develop-
ment and in cellular models in vitro. To our knowledge, this study
offers the first description of cell cycle phase-specific surface
expression of a growth factor receptor correlating with physio-
logical and molecular responses to the natural ligand, as initially
described in Rudkin et al. (1989). Studies of Zanellato et al.
(1993) in C6 glioma cells suggest that the cellular distribution of
TrkA might vary between a perinuclear and a membrane local-
ization as a function of the growth state. Others have observed
the preferential expression of a membrane protein, the neural
surface receptor p65/p95, during the S, G2, and M phases of the
cell cycle in mouse neural embryonic precursors (Rebai et al.,
1997). Clearly these observations speak to the fact that the
regulation of surface expression of membrane proteins during the
cell cycle may offer the cell another level of refinement in its
capacity to respond to the environment.
It is conceivable that other aspects of signaling infrastructure
also may vary according to the cell cycle phase. Indeed, NGF
treatment of PC12 cells affects the expression and activity of cell
cycle regulatory proteins, resulting in the accumulation of cells in
the G1 phase (Dobashi et al., 1995; Yan and Ziff, 1995; van
Grunsven et al., 1996a,b). The organization of chromatin also
varies throughout the cell cycle, as does nuclear transport, thus
offering further levels of controlling the growth factor response as
a function of cell cycle phase. The observations presented herein
leave us with numerous novel lines of study that should contribute
to understanding the mechanism of NGF action and perhaps that
of other neurotrophic factors and their receptors.
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